Search

Changes to Formulary as of 13th July 2021:

BNF Category Number

Product/indication

Detail of change

8.1.5

Acalabrutinib

Added as a RED drug and added link to NICE TA689

8.2.3

Avelumab

Added link to NICE TA691

8.1.5

Pembrolizumab

Added link to NICE TA692

 

8.1.5

Olaparib

Added link to NICE TA693

8.1.5

Carfilzomib

Added link to NICE TA695

2.14

Tafamidis

Added as a NOT APPROVED drug and added link to NICE TA696

2.12

Bempedoic acid

Added as a GREEN drug and added link to NICE TA689

2.8.3

Andexanet alfa

Changed from NOT APPROVED to RED drug and add link to NICE TA697

9.1.3a

Ravulizumab

Added as a RED drug and added link to NICE TA698

8.2.4

Ofatumumab

Added as a RED drug and added link to NICE TA699

13.5.3

Crisaborole

Added as a NOT APPROVED drug and added link to NICE TA701

8.1.5

Ibrutinib

Added link to NICE TA702

8.1.5

Ibrutinib

Added link to NICE TA703

8.1.5

Trastuzumab deruxtecan

Added as a RED drug and added link to NICE TA704

4

 

Added link to NICE NG193

5

 

Added link to NICE NG195

2

 

Added link to NICE NG196

1

Polyethylene glycol (PEG) laxatives and starch-based thickeners: potential interactive effect when mixed, leading to an increased risk of aspiration

Added link to MHRA Drug Safety Update

6.2.1

Levothyroxine: new prescribing advice for patients who experience symptoms on switching between different levothyroxine products

Added link to MHRA Drug Safety Update

15.2

Chloroprocaine Hydrochloride 1% Injection

Added as a RED drug

7.2.2

Nystatin 100,000 Pessaries (unlicensed)

Added as a RED drug

13.6.1

Epiduo® Gel 0.3% (Adapalene/Benzyl Peroxide)

Added as a GREEN drug

4.7.2

Diamorphine 500 microgram in 0.5ml sodium chloride 0.9% intrathecal pre-filled syringe (1x0.5ml) – for intrathecal use

Added as a RED drug

4.9.2

Procyclidine 5mg/5ml oral liquid

Added as am AMBER SI drug

11.8.1

Simple Eye Ointment

Deleted from formulary

6.3.1

Hydrocortisone sodium phosphate 100mg/ml IM Injection (Efcortesol)

Changed from NOT APPROVED to GREEN drug

6.2.2.2

Denosumab 60mg injection (Prolia®)

Clarified that first dose should be given in secondary care

8.3.4.1

Fulvestrant injection

Changed from NOT APPROVED to RED drug

2.6.1a

Bosentan for digital ulcers

Changed from NOT APPROVED to RED drug

2.6.1

Isosorbide Mononitrate 60mg MR tablets

Added as a GREEN drug

3.1.4

Bevespi Aerosphere

Added as a GREEN drug

3.2.3

Enerzair Breezhaler

Added as a GREEN drug

3.2.2

Atectura Breezhaler

Added as a GREEN drug

3.2.3

Trixeo Aerosphere

Added as a GREEN drug

3.2.1

Fluticasone

Deleted from formulary

3.2.1

QVAR Autohaler

Deleted from formulary

5.1.4

Neomycin 500mg tablets

Changed to unlicensed and RED drug